Valuation: Astellas Pharma Inc.

Market Cap 4,506B 28.55B 25.57B 23.59B 21.35B 39.92B 2,718B 40.56B 281B 112B 1,423B 107B 105B P/E 2027 *
11.4x
P/E 2028 * 12.4x
Enterprise Value 4,447B 28.17B 25.23B 23.28B 21.06B 39.39B 2,683B 40.03B 278B 111B 1,404B 106B 103B EV / Sales 2027 *
1.87x
EV / Sales 2028 * 1.82x
Free-Float
98.92%
Yield 2027 *
3.19%
Yield 2028 * 3.31%
1 day+0.26%
1 week+0.96%
Current month+10.03%
1 month+7.58%
3 months+14.14%
6 months+12.13%
Current year+19.80%
1 week 15.52
Extreme 15.52
16.48
1 month 13.48
Extreme 13.48
16.48
Current year 12.82
Extreme 12.8175
17.35
1 year 10.05
Extreme 10.05
17.35
3 years 8.37
Extreme 8.37
17.35
5 years 8.37
Extreme 8.37
18.18
10 years 8.37
Extreme 8.37
18.46
Manager TitleAgeSince
Chief Executive Officer 64 2023-02-09
Director of Finance/CFO 55 2023-10-31
Compliance Officer - 2025-03-31
Director TitleAgeSince
Chairman 66 2023-02-09
Director/Board Member 64 2019-05-31
Director/Board Member 59 2023-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.26%+0.96% - - 28.34B
+6.57%+4.62%+68.04%+141.66% 1,148B
+1.76%+2.66%+47.23%+86.85% 652B
+1.40%+1.43%+28.49%+103.88% 505B
+0.73%+2.45%+54.26%+66.47% 384B
+4.61%-0.27%+69.61%+43.01% 348B
+2.38%+2.65%+34.31%+56.33% 294B
+2.26%+0.55%+3.92%+27.74% 264B
+2.10%+2.82%+57.62%+74.73% 244B
+3.20%+3.63%+37.47%+109.46% 197B
Average +2.59%+1.39%+44.55%+78.90% 448.57B
Weighted average by Cap. +3.41%+1.50%+49.78%+93.15%

Financials

2027 *2028 *
Net sales 2,375B 15.04B 13.47B 12.43B 11.25B 21.03B 1,433B 21.37B 148B 59.16B 750B 56.45B 55.25B 2,213B 14.02B 12.56B 11.59B 10.49B 19.61B 1,335B 19.92B 138B 55.15B 699B 52.62B 51.5B
Net income 378B 2.39B 2.14B 1.98B 1.79B 3.35B 228B 3.4B 23.59B 9.41B 119B 8.98B 8.79B 346B 2.19B 1.96B 1.81B 1.64B 3.07B 209B 3.12B 21.61B 8.62B 109B 8.23B 8.05B
Net Debt -59.3B -376M -336M -310M -281M -525M -35.77B -534M -3.7B -1.48B -18.72B -1.41B -1.38B -481B -3.05B -2.73B -2.52B -2.28B -4.26B -290B -4.33B -30.02B -11.98B -152B -11.43B -11.18B
Projected Income Statement - Annual - Astellas Pharma Inc.
Logo Astellas Pharma Inc.
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Employees
14,099
Date Price Change Volume
26-10-29 US$15.92 +0.26% 62,210
26-10-28 US$15.88 -0.38% 68,334
26-10-27 US$15.94 -2.03% 97,190
26-10-26 US$16.27 +2.01% 60,038
26-10-23 US$15.95 +1.14% 95,873
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Astellas Pharma Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,513.00JPY
Average target price
2,536.43JPY
Spread / Average Target
+0.93%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Astellas Pharma Inc.